Key statistics
- Ranked Practice Areas
- 9
- Awards Won
- 6
- Ranked Lawyers
- 1
- Male:Female Ratio of Ranked Lawyers
- 0:1
Firm summary
Beijing Kangda Law Firm is a Domestic: Multi-practice firm in China.
In 2022, the firm was ranked in 9 practice area(s) and 1 of its practitioner(s) were accredited.
In the same year, Beijing Kangda Law Firm was nominated for 8 awards, of which it won 6.
This information is based on aggregated legal ranking and awards data from the world’s market-leading legal publications. Legal Media 360’s sentiment index methodology can be viewed here.
Rankings
within China
Practice Area Subcategory | BAND | No. of rankings | Ave. Band | Table | |
---|---|---|---|---|---|
Capital markets | |||||
Debt | BAND 4 | 1 | 4.0 | View full ranking table | |
Equity | BAND 4 | 1 | 4.0 | View full ranking table | |
General | BAND 3 | 3 | 3.0 | View full ranking table | |
Structured finance and securitisation | NOTABLE FIRMS | 1 | Notable | View full ranking table | |
Corporate and M&A | |||||
General | BAND 6 | 1 | 6.0 | View full ranking table | |
Dispute resolution | |||||
Commercial and transactions | BAND 4 | 1 | 4.0 | View full ranking table | |
General | BAND 3 | 3 | 3.5 | View full ranking table | |
Regulatory | |||||
Disputes | NOTABLE FIRMS | 1 | Notable | View full ranking table | |
Restructuring and insolvency | |||||
General | BAND 3 | 1 | 3.0 | View full ranking table |
Deals/Case awards
Total nominations-to-win ratio
2:0
Award | Nomination(s) | Win(s) |
---|---|---|
Banking and finance - Project finance | ||
Bangladesh Dhaka Bypass Expressway PPP | 1 | 0 |
Corporate and M&A - General | ||
Fangsheng Pharmaceutical and Baijun Medical's / DaVita equity transfer and debt equity swap | 1 | 0 |
Firm awards
Total nominations-to-win ratio
6:6
Award | Nomination(s) | Win(s) |
---|---|---|
Jurisdiction | ||
Dispute resolution | 1 | 1 |
Healthcare and lifesciences | 1 | 1 |
Insurance | 1 | 1 |
Regulatory | 1 | 1 |
Restructuring and insolvency | 1 | 1 |
Shipping | 1 | 1 |
Ranked lawyers at this firm
All data gathered from 2023 datasets. Learn more.